Mattia Carbotti
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Mattia Carbotti has a total of 65 co-authors. Here are the top co-authors by number of shared publications:
- Gabriele Arcari
Laboratory of Medical Microbiology and Virology, Department of Medicine and Technological Innovation, University of Insubria
5 shared publications - Nicasio Mancini
Department of Medicine and Innovation Technology, University of Insubria (DIMIT), Varese, Italy; Laboratory of Medical Microbiology and Virology University Hospital of Varese, Varese, Italy
5 shared publications Federica Novazzi
Laboratory of Medical Microbiology and Virology, ASST SetteLaghi, University Hospital of Varese
4 shared publicationsRiccardo Capuano
Laboratory of Medical Microbiology and Virology, ASST SetteLaghi, University Hospital of Varese
4 shared publicationsDomenico Caleca
Laboratory of Medical Microbiology and Virology, ASST SetteLaghi, University Hospital of Varese
3 shared publications- Paolo Gigante
Laboratory of Medical Microbiology and Virology, ASST SetteLaghi, University Hospital of Varese
3 shared publications
Latest Publications
- Open Access
- 29 October 2026
- Published by American Society for Microbiology in ASM Case Reports
Peritoneal infection due to Ochrobactrum anthropi producing a novel OCH beta-lactamase variant in a patient on peritoneal dialysis: case report and genomic analysis
Background: Peritoneal dialysis (PD)-associated peritonitis is a major cause of hospitalization, catheter loss, and technique failure. Ochrobactrum anthropi is an environmental, low-virulence, non-fermenting gram-negative bacillus that may cause device-associated infections and exhibits intrinsic beta-lactam resistance mediated by the chromosomal beta-lactamase bla OCH . Case Summary: A young adult with Bardet-Biedl syndrome receiving long-term PD presented with cloudy effluent, marked peritoneal leukocytosis, and minimal systemic symptoms. Empirical intraperitoneal cefazolin plus ceftazidime was initiated. Repeated peritoneal-fluid cultures yielded O. anthropi , whereas peripheral blood cultures remained negative. Susceptibility testing showed high MICs for beta-lactam/beta-lactamase inhibitor combinations and preserved carbapenem activity. Intravenous meropenem produced partial clinical improvement; however, fever and cloudy effluent recurred after treatment, requiring catheter removal. A new catheter was inserted 1 month later without recurrence.Whole-genome sequencing (WGS) was performed on the O. anthropi isolate recovered on day 11, the second culture-positive peritoneal-fluid sample, generating a 5.31-Mb draft genome used to confirm species assignment and identify resistance genes. The isolate carried a chromosomal ampR-ampC module encoding a novel OCH beta-lactamase variant, designated OCH-17. Conclusion: This case highlights O. anthropi as a device-associated PD pathogen and illustrates the importance of source control when infection persists despite targeted antimicrobial therapy. WGS supported species identification and characterized a novel chromosomal OCH variant.
- 29 October 2026
- Published by American Society for Microbiology in ASM Case Reports
Open AccessPeritoneal infection due to Ochrobactrum anthropi producing a novel OCH beta-lactamase variant in a patient on peritoneal dialysis: case report and genomic analysis
Background: Peritoneal dialysis (PD)-associated peritonitis is a major cause of hospitalization, catheter loss, and technique failure. Ochrobactrum anthropi is an environmental, low-virulence, non-fermenting gram-negative bacillus that may cause device-associated infections and exhibits intrinsic beta-lactam resistance mediated by the chromosomal beta-lactamase bla OCH . Case Summary: A young adult with Bardet-Biedl syndrome receiving long-term PD presented with cloudy effluent, marked peritoneal leukocytosis, and minimal systemic symptoms. Empirical intraperitoneal cefazolin plus ceftazidime was initiated. Repeated peritoneal-fluid cultures yielded O. anthropi , whereas peripheral blood cultures remained negative. Susceptibility testing showed high MICs for beta-lactam/beta-lactamase inhibitor combinations and preserved carbapenem activity. Intravenous meropenem produced partial clinical improvement; however, fever and cloudy effluent recurred after treatment, requiring catheter removal. A new catheter was inserted 1 month later without recurrence.Whole-genome sequencing (WGS) was performed on the O. anthropi isolate recovered on day 11, the second culture-positive peritoneal-fluid sample, generating a 5.31-Mb draft genome used to confirm species assignment and identify resistance genes. The isolate carried a chromosomal ampR-ampC module encoding a novel OCH beta-lactamase variant, designated OCH-17. Conclusion: This case highlights O. anthropi as a device-associated PD pathogen and illustrates the importance of source control when infection persists despite targeted antimicrobial therapy. WGS supported species identification and characterized a novel chromosomal OCH variant.
- Open Access
- 2 September 2026
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 70 (9)
Emergence and local dissemination of NDM-14-producing Klebsiella pneumoniae ST147: a phylodynamic and epidemiological investigation
NDM-14-producing Klebsiella pneumoniae ST147 has recently emerged as a high-risk clone in Europe, but its local dissemination dynamics remain poorly defined. We investigated a 6-month outbreak across three hospitals within a regional healthcare network in Lombardy, Northern Italy. Among 32 NDM-producing K. pneumoniae , isolated between December 2024 and May 2025, 19 belonged to ST147, including one NDM-1 producer and 18 carrying NDM-14 or its A233V variant NDM-61. Phylodynamic analysis of the ST147 NDM-14/NDM-61 genomes showed they were closely related (8–91 core SNPs) and descended from a most recent common ancestor dated to June 2024 (95% highest posterior density interval, 6 months). Reconstruction of the transmission network hints at the presence of at least three transmission clusters within the healthcare system: a major chain involving 11 of 18 cases spanning wards and facilities, a separate pair of linked cases, and 5 epidemiologically unlinked cases, suggesting missed intermediates or secondary introductions. The spread was characterized by rapid local expansion of the clone across intensive care, medical, and rehabilitation. These findings underscore the propensity of NDM-14-producing ST147 to disseminate efficiently within interconnected hospitals and highlight the need for enhanced genomic surveillance, coordinated infection control strategies, and judicious use of last-resort agents in regional healthcare networks. In a global phylogenetic context, the Italian isolates clustered within a broader NDM-14 ST147 population composed of several geographically distinct clades associated with France, Italy, Spain, Morocco, and the United Kingdom.
- 2 September 2026
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 70 (9)
Open AccessEmergence and local dissemination of NDM-14-producing Klebsiella pneumoniae ST147: a phylodynamic and epidemiological investigation
NDM-14-producing Klebsiella pneumoniae ST147 has recently emerged as a high-risk clone in Europe, but its local dissemination dynamics remain poorly defined. We investigated a 6-month outbreak across three hospitals within a regional healthcare network in Lombardy, Northern Italy. Among 32 NDM-producing K. pneumoniae , isolated between December 2024 and May 2025, 19 belonged to ST147, including one NDM-1 producer and 18 carrying NDM-14 or its A233V variant NDM-61. Phylodynamic analysis of the ST147 NDM-14/NDM-61 genomes showed they were closely related (8–91 core SNPs) and descended from a most recent common ancestor dated to June 2024 (95% highest posterior density interval, 6 months). Reconstruction of the transmission network hints at the presence of at least three transmission clusters within the healthcare system: a major chain involving 11 of 18 cases spanning wards and facilities, a separate pair of linked cases, and 5 epidemiologically unlinked cases, suggesting missed intermediates or secondary introductions. The spread was characterized by rapid local expansion of the clone across intensive care, medical, and rehabilitation. These findings underscore the propensity of NDM-14-producing ST147 to disseminate efficiently within interconnected hospitals and highlight the need for enhanced genomic surveillance, coordinated infection control strategies, and judicious use of last-resort agents in regional healthcare networks. In a global phylogenetic context, the Italian isolates clustered within a broader NDM-14 ST147 population composed of several geographically distinct clades associated with France, Italy, Spain, Morocco, and the United Kingdom.
- Open Access
- 6 May 2025
- Published by American Society for Microbiology in ASM Case Reports
- Vol. 1 (3)
Maggot-associated Ignatzschineria larvae bacteremia: a case report
Background: Myiases are fly larvae parasitic infections involving host tissues. In humans, myiases generally occur in people with reduced self-care capacity or living in poor hygienic conditions, with wounds serving as an entry point for flies. In addition to direct larvae damage, myiases constitute a risk factor for secondary bacterial infections. Case Summary: An 81-year-old patient with multiple comorbidities and living in poor hygienic conditions accessed the emergency room of a secondary care hospital in the Varese area following deterioration in his clinical condition and presence of maggots on his right leg. Blood cultures grew gram-negative bacilli, which could not be identified using standard procedures: biochemical tests yielded Pasteurella canis as a result with 95% probability, whereas matrix-assisted laser desorption ionization time-of-flight mass spectrometry could not find the spectrum in its database. The species Ignatzschineria larvae was determined by 16S rRNA sequencing, and its significance was interpreted upon consultation between microbiologists and clinicians. Conclusion: This case underscores the role of collaboration between clinical microbiology laboratories and clinicians in diagnosing and managing uncommon infections. The identification of I. larvae was obtained through 16S rRNA sequencing, highlighting how sequencing-based approaches are becoming increasingly implemented as diagnostic tools when traditional methods fail in identifying rare microorganisms.
- 6 May 2025
- Published by American Society for Microbiology in ASM Case Reports
- Vol. 1 (3)
Open AccessMaggot-associated Ignatzschineria larvae bacteremia: a case report
Background: Myiases are fly larvae parasitic infections involving host tissues. In humans, myiases generally occur in people with reduced self-care capacity or living in poor hygienic conditions, with wounds serving as an entry point for flies. In addition to direct larvae damage, myiases constitute a risk factor for secondary bacterial infections. Case Summary: An 81-year-old patient with multiple comorbidities and living in poor hygienic conditions accessed the emergency room of a secondary care hospital in the Varese area following deterioration in his clinical condition and presence of maggots on his right leg. Blood cultures grew gram-negative bacilli, which could not be identified using standard procedures: biochemical tests yielded Pasteurella canis as a result with 95% probability, whereas matrix-assisted laser desorption ionization time-of-flight mass spectrometry could not find the spectrum in its database. The species Ignatzschineria larvae was determined by 16S rRNA sequencing, and its significance was interpreted upon consultation between microbiologists and clinicians. Conclusion: This case underscores the role of collaboration between clinical microbiology laboratories and clinicians in diagnosing and managing uncommon infections. The identification of I. larvae was obtained through 16S rRNA sequencing, highlighting how sequencing-based approaches are becoming increasingly implemented as diagnostic tools when traditional methods fail in identifying rare microorganisms.
- Open Access
- 6 May 2025
- Published by American Society for Microbiology in Microbiology Spectrum
- Vol. 13 (5) , e0249424
Post-pandemic upsurge in Group A Streptococcus infections at an Italian tertiary university hospital
Streptococcus pyogenes (Group A Streptococcus ; GAS) is a pathogen of global significance. In the pre-antibiotic era, GAS was a major cause of childhood morbidity and mortality, but its spread rapidly declined until the mid-2010s. The continuing increase in GAS infections, associated with the expansion of the M1 UK lineage, was observed first in the United Kingdom (UK) and, later, globally. Here, we endeavor to assess the various determinants underlying the post-pandemic GAS upsurge, with a focus on microbial genomic features. We performed an epidemiological analysis of all laboratory-confirmed GAS infections identified between June 2018 and June 2024 at a tertiary University Hospital located in Northern Italy, dividing them into three levels of severity: mild, moderate, and invasive GAS infections. A subset of 34 representative GAS isolates identified in the post-pandemic period were subjected to short- and long-read whole genome sequencing (WGS). Of the 531 GAS cases analyzed during this period, the majority (415, 78.2%) occurred in the last two years. This increase in GAS cases correlated with a significant shift in infection severity: among the 118 GAS cases identified in the June 2018–May 2022 period, only one resulted in an invasive infection (1/118, 0.8%). In contrast, among the 531 GAS cases identified in the June 2022–May 2024 period, 32 caused invasive infections (32/531, 7.9%). WGS of 34 isolates (including 15 invasive isolates) identified 11 different emm types, the most frequent being emm 1 (9 isolates) followed by emm 12 (7 isolates), then emm 89 and emm 28 (4 isolates each). Among the emm 1 isolates, the M1 UK sublineage was the most represented (8 out of 9 isolates), with the remaining “singleton” belonging to the M1 13SNP sublineage. IMPORTANCE: Streptococcus pyogenes (GAS) is a narrow-spectrum pathogen, circulating only in humans. Following the loosening of various public health measures implemented to face the challenge of the COVID-19 pandemic, a significant rise in GAS cases has been observed. Our study revealed a significant rise in GAS cases, particularly invasive infections, over the last two years. Genomic analysis identified multiple sequence types, including isolates belonging to an emerging lineage named M1 UK . These findings underscore the importance of ongoing surveillance and genomic monitoring of GAS infections, especially considering their rising incidence and severity. Public health strategies should consider not only microbe-associated aspects but also host-associated and external factors to effectively address this resurgence and prevent future outbreaks.
- 6 May 2025
- Published by American Society for Microbiology in Microbiology Spectrum
- Vol. 13 (5) , e0249424
Open AccessPost-pandemic upsurge in Group A Streptococcus infections at an Italian tertiary university hospital
Streptococcus pyogenes (Group A Streptococcus ; GAS) is a pathogen of global significance. In the pre-antibiotic era, GAS was a major cause of childhood morbidity and mortality, but its spread rapidly declined until the mid-2010s. The continuing increase in GAS infections, associated with the expansion of the M1 UK lineage, was observed first in the United Kingdom (UK) and, later, globally. Here, we endeavor to assess the various determinants underlying the post-pandemic GAS upsurge, with a focus on microbial genomic features. We performed an epidemiological analysis of all laboratory-confirmed GAS infections identified between June 2018 and June 2024 at a tertiary University Hospital located in Northern Italy, dividing them into three levels of severity: mild, moderate, and invasive GAS infections. A subset of 34 representative GAS isolates identified in the post-pandemic period were subjected to short- and long-read whole genome sequencing (WGS). Of the 531 GAS cases analyzed during this period, the majority (415, 78.2%) occurred in the last two years. This increase in GAS cases correlated with a significant shift in infection severity: among the 118 GAS cases identified in the June 2018–May 2022 period, only one resulted in an invasive infection (1/118, 0.8%). In contrast, among the 531 GAS cases identified in the June 2022–May 2024 period, 32 caused invasive infections (32/531, 7.9%). WGS of 34 isolates (including 15 invasive isolates) identified 11 different emm types, the most frequent being emm 1 (9 isolates) followed by emm 12 (7 isolates), then emm 89 and emm 28 (4 isolates each). Among the emm 1 isolates, the M1 UK sublineage was the most represented (8 out of 9 isolates), with the remaining “singleton” belonging to the M1 13SNP sublineage. IMPORTANCE: Streptococcus pyogenes (GAS) is a narrow-spectrum pathogen, circulating only in humans. Following the loosening of various public health measures implemented to face the challenge of the COVID-19 pandemic, a significant rise in GAS cases has been observed. Our study revealed a significant rise in GAS cases, particularly invasive infections, over the last two years. Genomic analysis identified multiple sequence types, including isolates belonging to an emerging lineage named M1 UK . These findings underscore the importance of ongoing surveillance and genomic monitoring of GAS infections, especially considering their rising incidence and severity. Public health strategies should consider not only microbe-associated aspects but also host-associated and external factors to effectively address this resurgence and prevent future outbreaks.
- Open Access
- 25 July 2024
- Published by MDPI AG in Diagnostics
- Vol. 14 (15) , 1599
Combined Use of Phenotypic Screening and of a Novel Commercial Assay (REALQUALITY Carba-Screen) for the Rapid Molecular Detection of Carbapenemases: A Single-Center Experience
Carbapenem resistance is a serious public health threat, causing numerous deaths annually primarily due to healthcare-associated infections. To face this menace, surveillance programs in high-risk patients are becoming a widespread practice. Here we report the performance of the combined use of a recently approved commercial multiplex real-time PCR assay (REALQUALITY Carba-Screen kit) with conventional phenotypic screening. In this three-month study, 479 rectal swabs from 309 patients across high-risk units were evaluated by combining the two approaches. Although the molecular assay showed a higher positivity rate than phenotypic screening (7.1% vs. 5%), it should be noted that the molecular method alone would have missed eight carbapenem-resistant isolates, while using only phenotypic screening would not have detected sixteen isolates. This demonstrates the complementary strengths of each method. Our study confirms the need for a combined approach to maximize the possible clinical impact of this kind of screening, ensuring a more comprehensive detection of resistant strains.
- 25 July 2024
- Published by MDPI AG in Diagnostics
- Vol. 14 (15) , 1599
Open AccessCombined Use of Phenotypic Screening and of a Novel Commercial Assay (REALQUALITY Carba-Screen) for the Rapid Molecular Detection of Carbapenemases: A Single-Center Experience
Carbapenem resistance is a serious public health threat, causing numerous deaths annually primarily due to healthcare-associated infections. To face this menace, surveillance programs in high-risk patients are becoming a widespread practice. Here we report the performance of the combined use of a recently approved commercial multiplex real-time PCR assay (REALQUALITY Carba-Screen kit) with conventional phenotypic screening. In this three-month study, 479 rectal swabs from 309 patients across high-risk units were evaluated by combining the two approaches. Although the molecular assay showed a higher positivity rate than phenotypic screening (7.1% vs. 5%), it should be noted that the molecular method alone would have missed eight carbapenem-resistant isolates, while using only phenotypic screening would not have detected sixteen isolates. This demonstrates the complementary strengths of each method. Our study confirms the need for a combined approach to maximize the possible clinical impact of this kind of screening, ensuring a more comprehensive detection of resistant strains.
- Open Access
- 29 August 2018
- Published by Wiley in BioMed Research International
- Vol. 2018, 1-9
Efficacy of Ingenol Mebutate in the Treatment of Actinic Keratoses: A Pre- and Posttreatment Dermoscopic Comparative Analysis
Actinic keratosis (AK) is a common skin lesion in adults which usually occurs on chronically photoexposed areas and considered as a precancerous lesion or a superficial squamous-cell carcinoma. Many classifications have been proposed and its diagnosis is generally clinical but, sometimes, its wide variety of presentations can make diagnosis difficult, even among expert observers. The malignant potential of AKs imposes an early diagnosis and treatment in order to reduce morbidity and mortality, and, for the characterization of photodamaged skin, noninvasive diagnostic techniques, such as dermoscopy, have proved to be useful, while multiple therapeutic strategies, lesion-directed versus field-directed therapies, are available for the treatment of AKs. In this study, we evaluated the efficacy of ingenol mebutate for the treatment of AKs, with a particular focus on patients’ compliance, correlating it to clinical and dermoscopic grading, pre- and posttreatment, of these lesions. Fifty-two enrolled patients with AKs received treatment with ingenol mebutate gel (0.015% for face and scalp; 0.05% for trunk and extremities) and multiple dermatological evaluations. End points of the study were complete and partial clearance of clinically visible AKs on day 90. All acquired data were recorded and statistical analyses were performed. Univariate and multivariate analyses were used to identify possible predictive factors. We retrospectively analyzed patient-related and lesion-related factors to identify which variables, among age, gender, lesion site, pain, LSR score, and pretreatment clinical and dermoscopic grading, could independently predict the response to ingenol mebutate treatment. Our findings showed that pretreatment dermoscopic grade II represents an independent predictive factor of the efficacy of ingenol mebutate therapy (OR=14.78, 95% CI: 1.83–119.59, P=0.012) and that response rates differ on the basis of the treated anatomical sites (OR=0.16, 95% CI: 0.03–0.85, P=0.031). Data from this study provide evidence that ingenol mebutate gel is an effective treatment for AK, with relative ease of use, short exposure, and rapid resolution of local reactions, benefits contributing to high adherence of this therapy. Moreover, dermoscopic analysis of skin lesions offers more information than clinical evaluation alone and can be helpful in identifying different groups of AKs, thus selecting the adequate therapeutic choice.
- 29 August 2018
- Published by Wiley in BioMed Research International
- Vol. 2018, 1-9
Open AccessEfficacy of Ingenol Mebutate in the Treatment of Actinic Keratoses: A Pre- and Posttreatment Dermoscopic Comparative Analysis
Actinic keratosis (AK) is a common skin lesion in adults which usually occurs on chronically photoexposed areas and considered as a precancerous lesion or a superficial squamous-cell carcinoma. Many classifications have been proposed and its diagnosis is generally clinical but, sometimes, its wide variety of presentations can make diagnosis difficult, even among expert observers. The malignant potential of AKs imposes an early diagnosis and treatment in order to reduce morbidity and mortality, and, for the characterization of photodamaged skin, noninvasive diagnostic techniques, such as dermoscopy, have proved to be useful, while multiple therapeutic strategies, lesion-directed versus field-directed therapies, are available for the treatment of AKs. In this study, we evaluated the efficacy of ingenol mebutate for the treatment of AKs, with a particular focus on patients’ compliance, correlating it to clinical and dermoscopic grading, pre- and posttreatment, of these lesions. Fifty-two enrolled patients with AKs received treatment with ingenol mebutate gel (0.015% for face and scalp; 0.05% for trunk and extremities) and multiple dermatological evaluations. End points of the study were complete and partial clearance of clinically visible AKs on day 90. All acquired data were recorded and statistical analyses were performed. Univariate and multivariate analyses were used to identify possible predictive factors. We retrospectively analyzed patient-related and lesion-related factors to identify which variables, among age, gender, lesion site, pain, LSR score, and pretreatment clinical and dermoscopic grading, could independently predict the response to ingenol mebutate treatment. Our findings showed that pretreatment dermoscopic grade II represents an independent predictive factor of the efficacy of ingenol mebutate therapy (OR=14.78, 95% CI: 1.83–119.59, P=0.012) and that response rates differ on the basis of the treated anatomical sites (OR=0.16, 95% CI: 0.03–0.85, P=0.031). Data from this study provide evidence that ingenol mebutate gel is an effective treatment for AK, with relative ease of use, short exposure, and rapid resolution of local reactions, benefits contributing to high adherence of this therapy. Moreover, dermoscopic analysis of skin lesions offers more information than clinical evaluation alone and can be helpful in identifying different groups of AKs, thus selecting the adequate therapeutic choice.
- Open Access
- 1 January 2018
- Published by SAGE Publications in International Journal of Immunopathology and Pharmacology
- Vol. 32
Cutaneous candidiasis caused by Candida albicans in a young non-immunosuppressed patient: an unusual presentation
Candidiasis is a fungal infection caused by yeasts that belong to the genus Candida. There are over 20 species of Candida yeasts that can cause infection in humans, the most common of which is Candida albicans. Candida yeasts normally reside in the intestinal tract and can be found on mucous membranes and skin without causing infection. However, under immunocompromised conditions, Candida can cause significant infections in susceptible patients. Herein, we report a peculiar presentation of a C. albicans cutaneous infection in an immunocompetent young subject. This case widens our knowledge on the C. albicans infections both in terms of host susceptibility and cutaneous manifestations.
- 1 January 2018
- Published by SAGE Publications in International Journal of Immunopathology and Pharmacology
- Vol. 32
Open AccessCutaneous candidiasis caused by Candida albicans in a young non-immunosuppressed patient: an unusual presentation
Candidiasis is a fungal infection caused by yeasts that belong to the genus Candida. There are over 20 species of Candida yeasts that can cause infection in humans, the most common of which is Candida albicans. Candida yeasts normally reside in the intestinal tract and can be found on mucous membranes and skin without causing infection. However, under immunocompromised conditions, Candida can cause significant infections in susceptible patients. Herein, we report a peculiar presentation of a C. albicans cutaneous infection in an immunocompetent young subject. This case widens our knowledge on the C. albicans infections both in terms of host susceptibility and cutaneous manifestations.
- 16 October 2015
- Published by Wiley in International Journal of Dermatology
- Vol. 55 (6) , 653-656
Dermoscopy of verrucous epidermal nevus: large brown circles as a novel feature for diagnosis
Background: The epidermal nevus is a hamartomatous proliferation of the epithelium that can involve keratinocytes, sebaceous glands, the pilosebaceous unit, and eccrine or apocrine glands. It occurs in one in 1000 live births and most commonly presents as the verrucous type. Dermoscopy is a non‐invasive technique commonly used to differentiate between melanocytic and non‐melanocytic lesions.Objectives: This study was performed to analyze dermoscopic aspects of verrucous epidermal nevi, which have not previously been described.Methods: Dermoscopic analyses of eight different verrucous epidermal nevi were conducted. Each lesion was excised, and its diagnosis was histopathologically confirmed.Results: In non‐melanocytic lesions, a new dermoscopic feature of large brown circles was observed. This characteristic is useful in the diagnosis of verrucous epidermal nevi.Conclusions: Large brown circles represent a specific dermoscopic feature for the diagnosis of verrucous epidermal nevus.
- 16 October 2015
- Published by Wiley in International Journal of Dermatology
- Vol. 55 (6) , 653-656
Dermoscopy of verrucous epidermal nevus: large brown circles as a novel feature for diagnosis
Background: The epidermal nevus is a hamartomatous proliferation of the epithelium that can involve keratinocytes, sebaceous glands, the pilosebaceous unit, and eccrine or apocrine glands. It occurs in one in 1000 live births and most commonly presents as the verrucous type. Dermoscopy is a non‐invasive technique commonly used to differentiate between melanocytic and non‐melanocytic lesions.Objectives: This study was performed to analyze dermoscopic aspects of verrucous epidermal nevi, which have not previously been described.Methods: Dermoscopic analyses of eight different verrucous epidermal nevi were conducted. Each lesion was excised, and its diagnosis was histopathologically confirmed.Results: In non‐melanocytic lesions, a new dermoscopic feature of large brown circles was observed. This characteristic is useful in the diagnosis of verrucous epidermal nevi.Conclusions: Large brown circles represent a specific dermoscopic feature for the diagnosis of verrucous epidermal nevus.
- 1 June 2015
- Published by Elsevier in Journal of the American Academy of Dermatology
- Vol. 72 (6) , e143-e145
Use of dermoscopy in the diagnosis of sebaceoma
- 1 June 2015
- Published by Elsevier in Journal of the American Academy of Dermatology
- Vol. 72 (6) , e143-e145
Use of dermoscopy in the diagnosis of sebaceoma
- 14 March 2014
- Published by Wiley in Journal of the European Academy of Dermatology and Venereology
- Vol. 29 (5) , 1028-1029
Rhodotorula mucilaginosa skin infection in a patient treated with sorafenib
- 14 March 2014
- Published by Wiley in Journal of the European Academy of Dermatology and Venereology
- Vol. 29 (5) , 1028-1029
Rhodotorula mucilaginosa skin infection in a patient treated with sorafenib